GlassScriptPhysician profile
Suzanne R Rice
NPI 1780633164
$2,418.67
in general payments reported to CMS, 2019-2025
34 companies · $511 in 2025
The $511 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $219 · 2021: $194 · 2022: $325 · 2023: $528 · 2024: $413 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434 · Education: $17.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.16 |
| Education | $17.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $521.77 | 2019-2025 | |
| Coopersurgical, INC. | $201.38 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $199.34 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $167.08 | 2023-2024 | Sonicision, Ligasure, Cleancoat |
| Shield Therapeutics INC | $116.08 | 2023-2024 | Accrufer |
| Organon LLC | $107.28 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $89.38 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $85.81 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Myovant Sciences INC. | $82.78 | 2022 | |
| Novo Nordisk INC | $77.10 | 2024-2025 | Wegovy |
| Biogen, INC. | $69.65 | 2024-2025 | Zurzuvae |
| Ethicon US, LLC | $64.03 | 2020-2023 | Ethicon, Harmonic |
| Therapeuticsmd, INC. | $58.24 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $55.46 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.87 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $49.70 | 2025 | Myfembree |
| Idorsia Pharmaceuticals US INC | $42.85 | 2023 | Quviviq |
| Amag Pharmaceuticals, INC. | $42.35 | 2019-2020 | |
| Becton, Dickinson and Company | $38.09 | 2023-2024 | Bd Onclarity |
| Exeltis, USA INC. | $29.85 | 2022-2023 | Slynd |
| Allergan, INC. | $29.21 | 2019 | |
| Covidien LP | $27.58 | 2019 | |
| Teleflex LLC | $26.40 | 2025 | Quikclot |
| Aspira Women'S Health INC | $24.64 | 2022 | |
| Lundbeck LLC | $21.78 | 2025 | Rexulti |
| Pacira Pharmaceuticals Incorporated | $19.32 | 2020 | |
| Janssen Pharmaceuticals, INC | $19.30 | 2024 | Spravato |
| Heron Therapeutics, INC. | $17.50 | 2023 | Zynrelef |
| Merck Sharp & Dohme LLC | $16.46 | 2021 | |
| Axsome Therapeutics, INC. | $14.39 | 2025 | Symbravo |
| Innovation Technologies INC | $14.02 | 2025 | Irrisept |
| Daiichi Sankyo INC. | $13.97 | 2019 | |
| Abbott Laboratories | $13.24 | 2024 | Proclaim |
| Agile Therapeutics, INC. | $12.77 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.